You are here

  • Home
  • Archive
  • Volume 29, Issue Suppl 4
  • EP977 Impact of timing of cytoreductive surgery (CRS) on epithelial ovarian cancer (EOC), primary peritoneal carcinomatosis (PPC), and fallopian tube cancer (FTC) at american university of beirut medical center (AUBMC)

Citation Tools

Article menu
Download PDFPDF
ePoster
EP977 Impact of timing of cytoreductive surgery (CRS) on epithelial ovarian cancer (EOC), primary peritoneal carcinomatosis (PPC), and fallopian tube cancer (FTC) at american university of beirut medical center (AUBMC)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Seoud M, El Housheimi A, Jaafar I, et al
EP977 Impact of timing of cytoreductive surgery (CRS) on epithelial ovarian cancer (EOC), primary peritoneal carcinomatosis (PPC), and fallopian tube cancer (FTC) at american university of beirut medical center (AUBMC)
International Journal of Gynecologic Cancer 2019;29:A518.